Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Hendrawan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bone Marrow Transplantation|October 18, 2019
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseasesKevin Hendrawan, Malini Visweswaran, David D F Ma, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|March 16, 2017
The Regulation of Uterine Proinflammatory Gene Expression during Pregnancy in the Live-Bearing Lizard, Pseudemoia entrecasteauxiiKevin Hendrawan, Camilla M Whittington, Matthew C Brandley, et al.
Cytotherapy|September 22, 2023
Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplantJennifer Massey, Malini Visweswaran, Melissa Khoo, et al.
Frontiers in Immunology|February 7, 2022
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell TransplantationKevin Hendrawan, Melissa L M Khoo, Malini Visweswaran, et al.
Annals of Clinical and Translational Neurology|February 2, 2022
Sustained immunotolerance in multiple sclerosis after stem cell transplantMalini Visweswaran, Kevin Hendrawan, Jennifer C Massey, et al.
Frontiers in Immunology|February 24, 2022
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple SclerosisJennifer Massey, Katherine Jackson, Mandeep Singh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2018
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosisJohn J Moore, Jennifer C Massey, Carole D Ford, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bone Marrow Transplantation|October 18, 2019
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseasesKevin Hendrawan, Malini Visweswaran, David D F Ma, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|March 16, 2017
The Regulation of Uterine Proinflammatory Gene Expression during Pregnancy in the Live-Bearing Lizard, Pseudemoia entrecasteauxiiKevin Hendrawan, Camilla M Whittington, Matthew C Brandley, et al.
Cytotherapy|September 22, 2023
Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplantJennifer Massey, Malini Visweswaran, Melissa Khoo, et al.
Frontiers in Immunology|February 7, 2022
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell TransplantationKevin Hendrawan, Melissa L M Khoo, Malini Visweswaran, et al.
Annals of Clinical and Translational Neurology|February 2, 2022
Sustained immunotolerance in multiple sclerosis after stem cell transplantMalini Visweswaran, Kevin Hendrawan, Jennifer C Massey, et al.
Frontiers in Immunology|February 24, 2022
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple SclerosisJennifer Massey, Katherine Jackson, Mandeep Singh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2018
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosisJohn J Moore, Jennifer C Massey, Carole D Ford, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Pageof 1